X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-25 | CGEM | Jones Jeffrey Alan | Chief Medical Officer | S - Sale | $8.53 | -4,895 | 174,164 | -3% | -$41,754 | ||||||
2025-02-25 | CGEM | Ahmed Nadim | Pres, CEO | S - Sale | $8.53 | -12,529 | 430,621 | -3% | -$106,872 | ||||||
2025-02-25 | CGEM | Michaelson Jennifer | Chief Scientific Officer | S - Sale | $8.53 | -3,756 | 142,004 | -3% | -$32,039 | ||||||
2025-02-25 | CGEM | Sumer Jacquelyn L | GC | S - Sale | $8.53 | -3,756 | 136,895 | -3% | -$32,039 | ||||||
2025-01-06 | CGEM | Michaelson Jennifer | Chief Scientific Officer | S - Sale | $12.51 | -4,000 | 95,760 | -4% | -$50,040 | ||||||
2024-12-24 | CGEM | Ahmed Nadim | Pres, CEO | S - Sale | $11.87 | -8,400 | 263,150 | -3% | -$99,708 | ||||||
2024-12-18 | CGEM | Michaelson Jennifer | Chief Scientific Officer | S - Sale | $11.41 | -4,693 | 99,760 | -4% | -$53,547 | ||||||
2024-12-18 | CGEM | Jones Jeffrey Alan | Chief Medical Officer | S - Sale | $11.41 | -4,632 | 114,059 | -4% | -$52,851 | ||||||
2024-12-18 | CGEM | Sumer Jacquelyn L | GC | S - Sale | $11.41 | -3,482 | 90,651 | -4% | -$39,730 | ||||||
2024-12-12 | CGEM | Michaelson Jennifer | Chief Scientific Officer | S - Sale | $12.52 | -3,489 | 104,453 | -3% | -$43,682 | ||||||
2024-11-05 | CGEM | Michaelson Jennifer | Chief Scientific Officer | S - Sale | $15.64 | -8,000 | 107,942 | -7% | -$125,120 | ||||||
2024-09-05 | CGEM | Michaelson Jennifer | Chief Scientific Officer | S - Sale | $18.09 | -8,000 | 115,942 | -6% | -$144,720 | ||||||
2024-07-05 | CGEM | Michaelson Jennifer | Chief Scientific Officer | S - Sale | $16.33 | -8,000 | 123,942 | -6% | -$130,640 | ||||||
| DM | 2024-05-06 | CGEM | Michaelson Jennifer | Chief Scientific Officer | S - Sale+OE | $28.25 | -63,606 | 129,582 | -33% | -$1,796,676 | |||||
| D | 2024-02-01 | CGEM | Savill Corrine | Chief Business Officer | S - Sale+OE | $16.18 | -40,000 | 165,990 | -19% | -$647,200 | |||||
| D | 2024-01-29 | CGEM | Savill Corrine | Chief Business Officer | S - Sale+OE | $14.09 | -40,000 | 165,990 | -19% | -$563,600 | |||||
| DM | 2024-01-22 | CGEM | Savill Corrine | Chief Business Officer | S - Sale+OE | $12.31 | -40,000 | 165,990 | -19% | -$492,508 | |||||
2023-12-26 | CGEM | Ahmed Nadim | Pres, CEO | S - Sale | $9.24 | -4,272 | 111,550 | -4% | -$39,473 | ||||||
2023-12-21 | CGEM | Jones Jeffrey Alan | Chief Medical Officer | S - Sale | $8.50 | -1,860 | 56,191 | -3% | -$15,810 | ||||||
2023-12-21 | CGEM | Sumer Jacquelyn L | GC | S - Sale | $8.50 | -1,400 | 44,133 | -3% | -$11,900 | ||||||
2023-12-21 | CGEM | Trigilio Jeffrey | CFO | S - Sale | $8.50 | -1,920 | 83,919 | -2% | -$16,320 | ||||||
2023-12-21 | CGEM | Michaelson Jennifer | Chief Scientific Officer | S - Sale | $8.50 | -1,145 | 87,582 | -1% | -$9,733 | ||||||
2023-12-18 | CGEM | Jones Jeffrey Alan | Chief Medical Officer | S - Sale | $8.22 | -386 | 58,051 | -1% | -$3,173 | ||||||
2023-12-18 | CGEM | Michaelson Jennifer | Chief Scientific Officer | S - Sale | $8.22 | -238 | 88,727 | 0% | -$1,956 | ||||||
2023-12-18 | CGEM | Sumer Jacquelyn L | GC | S - Sale | $8.22 | -290 | 45,533 | -1% | -$2,384 | ||||||
2023-12-18 | CGEM | Trigilio Jeffrey | CFO | S - Sale | $8.22 | -398 | 85,839 | 0% | -$3,272 | ||||||
2023-12-12 | CGEM | Trigilio Jeffrey | CFO | S - Sale | $7.81 | -1,926 | 86,237 | -2% | -$15,042 | ||||||
2023-12-12 | CGEM | Michaelson Jennifer | Chief Scientific Officer | S - Sale | $7.81 | -1,068 | 88,965 | -1% | -$8,341 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |